Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Methylglyoxal | HCID 880 | — |
| Reactant | Methylamine | HCID 6329 | — |
| Reactant | Ethylamine | HCID 6341 | — |
| Reactant | Glyoxal | HCID 7860 | — |
| Product | 1,4-Dimethylimidazole | HCID 138733 | — |
| Product | 1,2,4-Trimethyl-1H-imidazole | HCID 14717865 | — |
Reaction Steps
The same procedure as in Example 1 was performed except that 38 parts of methylamine (as a 40% aqueous solution) was used in lieu of ethylamine (as a 70% aqueous solution), and 87 parts of methyl glyoxal was used in lieu of glyoxal (as a 40% aqueous solution). After the dropwise addition, a mixture comprising 1,2,4-trimethylimidazole (a-3) and 1,4-dimethylimidazole (b-3) was obtained. The obtained mixture was analyzed with HPLC to find that the weight ratio of (a-3) to (b-3) was 80:20. The mixture was further purified by distillation under the temperature and pressure conditions of 110° C. and 1.0 kPA, and the weight ratio of (a-3) to (b-3) after the purification was 85:15 (M-11). The obtained mixture was treated in the same manner as in Example 1 to obtain a mixture comprising 1,2,3,4-tetramethylimidazolium tetrafluoroborate (hereinafter, referred to as “TeMI”) and 1,3,4-trimethylimidazolium tetrafluoroborate (hereinafter, referred to as “4TMI”). By the HPLC analysis, the weight ratio between them was found to be 85:15. 212 g of the obtained mixture comprising TeMI and 4TMI was dissolved in propylene carbonate homogeneously so as to adjust the total amount to 1 liter to prepare the electrolyte solution of the present invention.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08007680B2 |
|---|
| Source dataset | uspto-grants-2011_08 |
|---|
| ORD ID | ord-61730ba8c73c4de9a18a8357c6ece048 |
|---|
| Source note | uspto-grants-2011_08 |
|---|